ArticleFrontiers in medicine2025
A scoping review of advancements in machine learning for glaucoma: current trends and future direction.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning identifies pupil size and corneal thickness as key predictors of axial elongation rate.PloS one · 2026Article
- MSLI-Net: retinal disease detection network based on multi-segment localization and multi-scale interaction.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Machine learning technology has demonstrated significant potential in glaucoma research, particularly in early diagnosis, predicting disease progression, evaluating treatment responses, and developing personalized treatment strategies. The application of machine learning not only enhances the understanding of the pathological mechanism of glaucoma and optimizes the diagnostic process but also provides patients with accurate medical services. Methods: This study aimed to describe the current state of research, highlight directions for further development, and identify potential trends for improvement. This review was conducted following the scoping review of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension to showcase advancements in the application of machine learning in glaucoma research and treatment. Results: We employed a comprehensive search strategy to retrieve literature from the Web of Science Core Collection database, ultimately including 3,581 articles in the analysis. Through data analysis, we identified current research hotspots, noted differences in researchers' attitudes and opinions, and predicted potential future development trends. Discussion: We divided the research topics into six categories, clearly identifying "eye diseases", "retinal fundus imaging" and "risk factors" as the key terms for the development of this field. These findings signify the promising prospects of machine learning, particularly when integrated with multimodal technologies and large language models, to enhance the diagnosis and treatment of glaucoma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.